Recent studies have revealed that PDCD6 overexpression can promote the progression of hepatomas, breast, and ovarian cancer, suggesting that PDCD6 might be involved in the maintenance of cellular viability [21–23]. The gene discussed is PDCD6; the disease is hepatocellular carcinoma.